Current Brachytherapy News and Events

Current Brachytherapy News and Events, Brachytherapy News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 6 | 224 Results
Radioactive bone cement found to be safer in treating spinal tumors
A radioactive bone cement that's injected into bone to provide support and local irradiation is proving to be a safer alternative to conventional radiation therapy for bone tumors, according to a study led by University of California, Irvine researchers. (2021-02-16)

Cervical cancer survival may improve by targeting senescent "zombie" cells
How well women with cervical cancer respond to treatment and survive correlates with the level of 10 proteins in their blood that also are associated with a ''zombie'' cell state called senescence, Medical College of Georgia scientists report. (2020-12-07)

Outcomes of salvage low dose RT brachytherapy after EBRT for prostate cancer
Researchers involved in the phase II NRG Oncology RTOG 0526 trial studying low dose rate (LDR) prostate brachytherapy (BT) following local recurrence (LR) after external beam radiotherapy (EBRT) for patients with low-to-intermediate risk prostate cancer reported late Grade 3 gastrointestinal and genitourinary adverse events (AEs) occurring in 14% of trial participants. (2020-10-28)

Antibodies against sugars, internal radiation: Powerful package against cervical cancer
The sugar coating on cancer cells helps them thrive, and a new study indicates patients with cervical cancer who make antibodies to those sugars appear to do better when they also receive internal radiation therapy. (2020-06-16)

ASTRO issues first clinical guideline on radiation therapy for cervical cancer
A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations for radiation therapy to treat patients with nonmetastatic cervical cancer. The guideline--ASTRO's first for cervical cancer--outlines indications and best practices for external beam radiation therapy and brachytherapy in the postoperative and definitive settings. Recommendations also address other treatments including chemotherapy and surgery when used in combination with radiation. The guideline is published online in Practical Radiation Oncology. (2020-06-10)

Study examines prostate cancer treatment decisions
A five-year follow-up study of more than 2,000 US men who received prostate cancer treatment is creating a road map for future patients regarding long-term bowel, bladder and sexual function in order to clarify expectations and enable men to make informed choices about care. (2020-01-27)

Brachytherapy proves effective in treating skin cancer
The use of high-dose-rate brachytherapy to treat elderly patients with common skin cancers offers excellent cure rates and cosmetic outcomes, according to a new study. (2019-12-04)

Aesthetics of skin cancer therapy may vary by treatment type
In a meta-analysis of 58 studies, a study led by Penn State compared four types of skin cancer treatments and found that while all four had similar recurrence rates a year after treatment, a form of radiation called brachytherapy and a type of surgery called Mohs micrographic surgery had better cosmetic results. (2019-09-03)

Single dose of targeted radiotherapy is safe and effective for prostate cancer
A single high dose of radiation that can be delivered directly to the tumor within a few minutes is a safe and effective technique for treating men with low-risk prostate cancer, according to a study presented at the ESTRO 38 conference. (2019-04-28)

Benefit of LDR brachytherapy in patients with early-stage prostate cancer is still unclear
Even eleven years after the first benefit assessment, the evidence base remains inadequate. The hopes to be able to close gaps in knowledge were disappointed when PREFERE failed in 2016 due to a lack of interest. (2018-11-19)

PROs indicate brachytherapy alone is the superior treatment
Patient-Reported Outcomes (PROs) from the NRG Oncology trial RTOG 0232 comparing a combined treatment of external beam therapy and brachytherapy (EBT+B) to transperineal interstitial permanent brachytherapy (B) alone indicate a significantly different clinician and patient-reported late toxicity profile between arms despite similarities in progression-free survival results. This abstract was presented at the American Society for Radiation Oncology (ASTRO) annual meeting and was awarded as a Best of ASTRO presentation for 2018. (2018-10-21)

Brachytherapy for cervical cancer does not increase the risk of ureteral stricture
New research presented at the ESTRO 37 conference from two large international trials, shows that intracavitary and interstitial brachytherapy is safe and does not increase the risk of ureteral stricture in cervical cancer patients. Until now, there have been concerns that brachytherapy might increase the risk of this serious, sometimes life-threatening complication, although the treatment itself is associated with better survival. (2018-04-20)

Does single PSA test have effect on prostate cancer detection, death?
A screening program that invited men to a clinic to undergo a single prostate-specific antigen (PSA) test increased detection of low-risk prostate cancer but made no significant difference in prostate cancer deaths after 10 years. (2018-03-06)

VCU scientists seek to perfect calculations for comparing cervical cancer radiation doses
Research from VCU Massey Cancer Center has found that one of the standard practices for comparing cervical cancer radiation therapy treatments may be misleading, and the use of an alternative mathematical formula could be used to more effectively predict and potentially improve outcomes for patients. (2018-02-06)

MD Anderson study evaluates need for biopsies during follow-up care in women with early breast cancer
In an analysis of more than 120,000 women diagnosed with and treated for early-stage breast cancer, researchers from The University of Texas MD Anderson Cancer Center determined the rate of additional breast biopsies needed for these patients during their follow-up care. The findings, reported in JAMA Surgery, are the first comprehensive nationwide population-based study regarding the need for breast biopsies performed during follow up after treatment for invasive breast cancer. (2018-01-31)

A gold-standard cancer treatment is in decline, and money may be why
Offering brachytherapy for locally advanced cervical cancer ends up costing hospitals money, potentially explaining its declining use even though it's considered the most effective treatment. (2017-12-12)

Cleveland Clinic leads development of new guidelines for radiation in breast cancer
Cleveland Clinic researcher Chirag Shah, M.D., led the development of updated guidelines for the appropriate and safe utilization of accelerated partial-breast irradiation (APBI). The guidelines are published online in the journal, Brachytherapy. (2017-10-26)

Queen's University Belfast leads study to transform prostate cancer treatment
Queen's University Belfast has led the world's largest research study using a diagnostic test developed by Almac Diagnostics, to better understand the biology of prostate cancer tumours, which could lead to a transformation in how prostate cancer is diagnosed and treated. (2017-10-23)

Trial confirms pelvic radiation as standard of care for high-risk endometrial cancer
In a new phase III trial report from the National Clinical Trial Network group, NRG Oncology, recurrence-free and overall survival rates for women with stage I-II high-risk endometrial cancer were not superior following vaginal cuff brachytherapy plus chemotherapy when compared with pelvic radiation therapy. (2017-09-25)

ASTRO supports US Nuclear Regulatory Commission final rule
The American Society for Radiation Oncology (ASTRO) applauds the United States Nuclear Regulatory Commission for yesterday's announcement of a final rule that updates the definition of medical events for permanent implant brachytherapy and protects patients' access to this treatment. (2017-08-18)

Giving a single, high dose of radiation directly to the site of a prostate tumor is safe
Doctors have found that treating prostate cancer with a single, high dose of radiation delivered precisely to the site of the tumor results in good quality of life and fewer trips to the hospital, with adverse side effects that are no worse than if the radiation treatment had been given in several lower doses. The research is presented at the 36th annual congress of the European SocieTy for Radiotherapy & Oncology (ESTRO 36). (2017-05-06)

ESTRO announces GIRO: A project to save one million lives in under 20 years
ESTRO aims to save one million lives by 2035 with the launch of a new partnership to bring radiotherapy to countries where its provision is lacking. (2017-05-04)

Cervical cancer survivors suffer from fatigue, insomnia and hot flushes
Around half of women who have been treated for locally advanced cervical cancer suffer from symptoms of insomnia, fatigue or hot flushes at some point, according to new research presented at the ESTRO 36 conference. (2017-05-04)

Type of treatment for prostate cancer affects quality of life
Quality of life after prostate cancer treatment varies by the type of treatment patients receive, a new study reveals. (2017-04-20)

Different breast cancer treatment options vary widely in their cost-effectiveness
A new study published today in the Journal of the National Cancer Institute indicates that different therapies for early-stage breast cancer have very different relative values. Some therapies may have fewer complications and be much less expensive than others. Women may be making treatment decisions based on factors other than medical value. (2017-04-10)

ASCO and Cancer Care Ontario update guideline on radiation therapy for prostate cancer
The American Society of Clinical Oncology (ASCO) and Cancer Care Ontario today issued a joint clinical practice guideline update on brachytherapy (internal radiation) for patients with prostate cancer. The update provides evidence-based recommendations for different patient risk groups, and specifies the most effective forms of brachytherapy. (2017-03-28)

Adverse effects, quality of life of treatment vs. no treatment for men with localized prostate cancer
Two studies published by JAMA examine the adverse effects and quality of life as reported by men with localized prostate cancer who chose treatment, observation or active surveillance. (2017-03-21)

New insights into side effects can help prostate cancer patients choose treatments
A new study led by UNC Lineberger Comprehensive Cancer Center researchers identifies distinct patterns of side effects for modern-day prostate cancer treatments that patients could use to guide their choices. (2017-03-21)

Media can register now for ESTRO 36 - Europe's largest congress on radiation oncology
Journalists can register now for ESTRO 36 - Europe's largest congress on radiation oncology, organised by the European Society for Radiotherapy and Oncology (ESTRO). (2017-03-01)

Single dose of brachytherapy may be an effective treatment for localized prostate cancer
Results from a new prospective clinical trial indicate that high-dose-rate (HDR) brachytherapy administered in a single, 19 Gray (Gy) treatment may be a safe and effective alternative to longer courses of HDR treatment for men with localized prostate cancer. (2017-03-01)

Older women with breast cancer report better cosmetic satisfaction with less radiation, less surgery
In the first study evaluating patient-reported cosmetic outcomes in a population-based cohort of older women with breast cancer, The University of Texas MD Anderson Cancer Center researchers found that less radiation was associated with improved cosmetic satisfaction long-term. (2016-12-09)

William Small, Jr., M.D., named Loyola Senior Scientist of the Year
William Small, Jr., M.D., F.A.C.R.O., F.A.C.R., F.A.S.T.R.O., chair of the department of radiation oncology, has been named Loyola University Chicago Stritch School of Medicine's Senior Scientist of the Year. (2016-11-28)

Less than half of cervical cancer patients receive standard-of-care treatment
University of Colorado Cancer Center study shows that only 44 percent of patients in a large, national sample received all three components of standard-of-care treatment for cervical cancer, most often lacking brachytherapy. (2016-10-31)

Addition of EBT to brachytherapy does not produce superior PFS results
NRG Oncology researchers reported that adding external radiation therapy to standard brachytherapy did not improve progression-free survival for men with intermediate-risk prostate cancer. (2016-10-03)

African-American men negatively impacted by hormone therapy for treatment of prostate cancer
In a retrospective study analyzing patients' medical records, researchers at Brigham and Women's Hospital found that patients' race significantly affected their longevity by increasing the likelihood of death after receiving androgen deprivation therapy. (2016-08-04)

New ASTRO clinical practice statement updates treatment standard for rectal cancer
The American Society for Radiation Oncology (ASTRO) recently issued a new clinical practice statement, 'Appropriate Customization of Radiation Therapy for Stage II and III Rectal Cancer: An ASTRO Clinical Practice Statement Using the RAND/UCLA Appropriateness Method.' (2016-07-21)

Brachytherapy pioneer Haakon Ragde, M.D., chosen as ASTRO 2016 Honorary Member
The American Society for Radiation Oncology (ASTRO) has selected Haakon Ragde, M.D., as its 2016 Honorary Member, the highest honor ASTRO bestows on distinguished cancer researchers, scientists and leaders in disciplines other than radiation oncology, radiobiology or radiation physics. (2016-06-28)

Radiation and immunotherapy combination can destroy both primary and secondary tumors
Research to be presented to the ESTRO 35 conference today has shown that the addition of an immune system-strengthening compound to radiation therapy can extend the radiation therapy-induced immune response against the tumor sites and that this response even has an effect on tumors outside the radiation field. (2016-04-30)

Hormone therapy for prostate cancer may increase risk of depression
A new study led by researchers at Brigham and Women's Hospital has found a significant association between depression and patients being treated for localized prostate cancer by androgen deprivation therapy. (2016-04-11)

An invitation to ESTRO 35
The ESTRO 35 congress will feature new research results in clinical radiation oncology, radiobiology, physics, technology, patient care, radiation therapy and brachytherapy, presented by top doctors, scientists and radiation therapists from all over the world, working together for the benefit of cancer patients. The congress is expected to attract 5,000 delegates from more than 80 countries. (2016-01-26)

Page 1 of 6 | 224 Results
   First   Previous   Next      Last is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to